ID   BAAT_HUMAN              Reviewed;         418 AA.
AC   Q14032; Q3B7W9; Q96L31;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   12-APR-2017, entry version 140.
DE   RecName: Full=Bile acid-CoA:amino acid N-acyltransferase {ECO:0000303|PubMed:8034703};
DE            Short=BACAT {ECO:0000303|PubMed:12810727};
DE            Short=BAT {ECO:0000303|PubMed:8034703};
DE            EC=2.3.1.65 {ECO:0000269|PubMed:12810727, ECO:0000269|PubMed:8034703};
DE   AltName: Full=Glycine N-choloyltransferase;
DE   AltName: Full=Long-chain fatty-acyl-CoA hydrolase {ECO:0000303|PubMed:12810727};
DE            EC=3.1.2.2 {ECO:0000269|PubMed:12810727};
GN   Name=BAAT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 1-17, FUNCTION,
RP   CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   TISSUE=Liver;
RX   PubMed=8034703;
RA   Falany C.N., Johnson M.R., Barnes S., Diasio R.B.;
RT   "Glycine and taurine conjugation of bile acids by a single enzyme.
RT   Molecular cloning and expression of human liver bile acid CoA:amino
RT   acid N-acyltransferase.";
RL   J. Biol. Chem. 269:19375-19379(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-20.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLN-20.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-20.
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY, CATALYTIC ACTIVITY, SUBUNIT, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RC   TISSUE=Liver;
RX   PubMed=2037576;
RA   Johnson M.R., Barnes S., Kwakye J.B., Diasio R.B.;
RT   "Purification and characterization of bile acid-CoA:amino acid N-
RT   acyltransferase from human liver.";
RL   J. Biol. Chem. 266:10227-10233(1991).
RN   [7]
RP   MUTAGENESIS OF CYS-235; ASP-328 AND HIS-362.
RX   PubMed=12239217; DOI=10.1074/jbc.M207463200;
RA   Sfakianos M.K., Wilson L., Sakalian M., Falany C.N., Barnes S.;
RT   "Conserved residues in the putative catalytic triad of human bile acid
RT   Coenzyme A:amino acid N-acyltransferase.";
RL   J. Biol. Chem. 277:47270-47275(2002).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF CYS-235; ASP-328; HIS-362 AND GLN-417.
RX   PubMed=12810727; DOI=10.1074/jbc.M300987200;
RA   O'Byrne J., Hunt M.C., Rai D.K., Saeki M., Alexson S.E.;
RT   "The human bile acid-CoA:amino acid N-acyltransferase functions in the
RT   conjugation of fatty acids to glycine.";
RL   J. Biol. Chem. 278:34237-34244(2003).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   VARIANT FHCA VAL-76.
RX   PubMed=12704386; DOI=10.1038/ng1147;
RA   Carlton V.E.H., Harris B.Z., Puffenberger E.G., Batta A.K.,
RA   Knisely A.S., Robinson D.L., Strauss K.A., Shneider B.L., Lim W.A.,
RA   Salen G., Morton D.H., Bull L.N.;
RT   "Complex inheritance of familial hypercholanemia with associated
RT   mutations in TJP2 and BAAT.";
RL   Nat. Genet. 34:91-96(2003).
CC   -!- FUNCTION: Involved in bile acid metabolism. In liver hepatocytes
CC       catalyzes the second step in the conjugation of C24 bile acids
CC       (choloneates) to glycine and taurine before excretion into bile
CC       canaliculi. The major components of bile are cholic acid and
CC       chenodeoxycholic acid. In a first step the bile acids are
CC       converted to an acyl-CoA thioester, either in peroxisomes (primary
CC       bile acids deriving from the cholesterol pathway), or cytoplasmic
CC       at the endoplasmic reticulum (secondary bile acids). May catalyze
CC       the conjugation of primary or secondary bile acids, or both. The
CC       conjugation increases the detergent properties of bile acids in
CC       the intestine, which facilitates lipid and fat-soluble vitamin
CC       absorption. In turn, bile acids are deconjugated by bacteria in
CC       the intestine and are recycled back to the liver for reconjugation
CC       (secondary bile acids). May also act as an acyl-CoA thioesterase
CC       that regulates intracellular levels of free fatty acids. In vitro,
CC       catalyzes the hydrolysis of long- and very long-chain saturated
CC       acyl-CoAs to the free fatty acid and coenzyme A (CoASH), and
CC       conjugates glycine to these acyl-CoAs.
CC       {ECO:0000269|PubMed:12810727, ECO:0000269|PubMed:8034703}.
CC   -!- CATALYTIC ACTIVITY: Choloyl-CoA + glycine = CoA + glycocholate.
CC       {ECO:0000269|PubMed:12810727, ECO:0000269|PubMed:8034703}.
CC   -!- CATALYTIC ACTIVITY: Palmitoyl-CoA + H(2)O = CoA + palmitate.
CC       {ECO:0000269|PubMed:12810727}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.1 mM for taurine toward choloyl-CoA
CC         {ECO:0000269|PubMed:2037576, ECO:0000269|PubMed:8034703};
CC         KM=2.2 mM for 2-fluoro-beta-alanine toward choloyl-CoA
CC         {ECO:0000269|PubMed:2037576, ECO:0000269|PubMed:8034703};
CC         KM=5.8 mM for glycine toward choloyl-CoA
CC         {ECO:0000269|PubMed:2037576, ECO:0000269|PubMed:8034703};
CC         KM=19.3 uM for arachidoyl-CoA {ECO:0000269|PubMed:8034703};
CC         Vmax=0.33 umol/min/mg enzyme with taurine as substrate for
CC         acyltransferase activity {ECO:0000269|PubMed:2037576,
CC         ECO:0000269|PubMed:8034703};
CC         Vmax=0.19 umol/min/mg enzyme with 2-fluoro-beta-alanine as
CC         substrate for acyltransferase activity
CC         {ECO:0000269|PubMed:8034703};
CC         Vmax=0.77 umol/min/mg enzyme with glycine as substrate for
CC         acyltransferase activity {ECO:0000269|PubMed:2037576,
CC         ECO:0000269|PubMed:8034703};
CC         Vmax=223 nmol/min/mg enzyme with arachidoyl-CoA as substrate for
CC         acyl-CoA thioesterase activity {ECO:0000269|PubMed:8034703};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:2037576}.
CC   -!- INTERACTION:
CC       Q0D2H9:GOLGA8DP; NbExp=5; IntAct=EBI-8994378, EBI-10181276;
CC       Q08AF8:GOLGA8G; NbExp=3; IntAct=EBI-8994378, EBI-10181260;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12810727}.
CC   -!- TISSUE SPECIFICITY: Expressed in liver, gallbladder mucosa and
CC       pancreas. {ECO:0000269|PubMed:12810727,
CC       ECO:0000269|PubMed:2037576}.
CC   -!- DISEASE: Familial hypercholanemia (FHCA) [MIM:607748]: A disorder
CC       characterized by elevated serum bile acid concentrations, itching,
CC       and fat malabsorption. {ECO:0000269|PubMed:12704386}. Note=The
CC       disease may be caused by mutations affecting distinct genetic
CC       loci, including the gene represented in this entry.
CC   -!- MISCELLANEOUS: In human, more than 95% of the biliary bile acids
CC       are N-acyl amidates with glycine and taurine. In other mammalian
CC       species large differences are observed in the relative amounts of
CC       taurine- and glycine-conjugated bile acids formed in bile.
CC   -!- SIMILARITY: Belongs to the C/M/P thioester hydrolase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L34081; AAC37550.1; -; mRNA.
DR   EMBL; CR541918; CAG46716.1; -; mRNA.
DR   EMBL; AL359893; CAH72995.1; -; Genomic_DNA.
DR   EMBL; CH471105; EAW58943.1; -; Genomic_DNA.
DR   EMBL; BC009567; AAH09567.1; -; mRNA.
DR   EMBL; BC107424; AAI07425.1; -; mRNA.
DR   CCDS; CCDS6752.1; -.
DR   PIR; A53965; A53965.
DR   RefSeq; NP_001121082.1; NM_001127610.1.
DR   RefSeq; NP_001692.1; NM_001701.3.
DR   UniGene; Hs.284712; -.
DR   ProteinModelPortal; Q14032; -.
DR   SMR; Q14032; -.
DR   BioGrid; 107046; 5.
DR   IntAct; Q14032; 21.
DR   STRING; 9606.ENSP00000259407; -.
DR   DrugBank; DB00145; Glycine.
DR   SwissLipids; SLP:000001309; -.
DR   ESTHER; human-BAAT; Acyl-CoA_Thioesterase.
DR   MEROPS; S09.A50; -.
DR   iPTMnet; Q14032; -.
DR   PhosphoSitePlus; Q14032; -.
DR   BioMuta; BAAT; -.
DR   DMDM; 74739811; -.
DR   MaxQB; Q14032; -.
DR   PaxDb; Q14032; -.
DR   PeptideAtlas; Q14032; -.
DR   PRIDE; Q14032; -.
DR   DNASU; 570; -.
DR   Ensembl; ENST00000259407; ENSP00000259407; ENSG00000136881.
DR   Ensembl; ENST00000395051; ENSP00000378491; ENSG00000136881.
DR   Ensembl; ENST00000621712; ENSP00000484063; ENSG00000276559.
DR   GeneID; 570; -.
DR   KEGG; hsa:570; -.
DR   UCSC; uc010mtd.3; human.
DR   CTD; 570; -.
DR   DisGeNET; 570; -.
DR   GeneCards; BAAT; -.
DR   HGNC; HGNC:932; BAAT.
DR   HPA; HPA021251; -.
DR   HPA; HPA021330; -.
DR   MalaCards; BAAT; -.
DR   MIM; 602938; gene.
DR   MIM; 607748; phenotype.
DR   neXtProt; NX_Q14032; -.
DR   OpenTargets; ENSG00000136881; -.
DR   Orphanet; 238475; Familial hypercholanemia.
DR   PharmGKB; PA25231; -.
DR   eggNOG; ENOG410II3X; Eukaryota.
DR   eggNOG; COG1073; LUCA.
DR   GeneTree; ENSGT00390000001046; -.
DR   HOGENOM; HOG000116219; -.
DR   HOVERGEN; HBG000331; -.
DR   InParanoid; Q14032; -.
DR   KO; K00659; -.
DR   OMA; NMFYSQA; -.
DR   OrthoDB; EOG091G08KU; -.
DR   PhylomeDB; Q14032; -.
DR   TreeFam; TF314911; -.
DR   BRENDA; 2.3.1.65; 2681.
DR   Reactome; R-HSA-159418; Recycling of bile acids and salts.
DR   Reactome; R-HSA-193368; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol.
DR   SABIO-RK; Q14032; -.
DR   GeneWiki; BAAT; -.
DR   GenomeRNAi; 570; -.
DR   PRO; PR:Q14032; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000136881; -.
DR   CleanEx; HS_BAAT; -.
DR   Genevisible; Q14032; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005782; C:peroxisomal matrix; TAS:Reactome.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0052689; F:carboxylic ester hydrolase activity; IEA:UniProtKB-KW.
DR   GO; GO:0047963; F:glycine N-choloyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0052816; F:long-chain acyl-CoA hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0052815; F:medium-chain acyl-CoA hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0102991; F:myristoyl-CoA hydrolase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016410; F:N-acyltransferase activity; IDA:MGI.
DR   GO; GO:0016290; F:palmitoyl-CoA hydrolase activity; IEA:UniProtKB-EC.
DR   GO; GO:0005102; F:receptor binding; IPI:UniProtKB.
DR   GO; GO:0016746; F:transferase activity, transferring acyl groups; TAS:Reactome.
DR   GO; GO:0052817; F:very long chain acyl-CoA hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0006637; P:acyl-CoA metabolic process; IDA:UniProtKB.
DR   GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
DR   GO; GO:0006699; P:bile acid biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0002152; P:bile acid conjugation; IDA:UniProtKB.
DR   GO; GO:0008206; P:bile acid metabolic process; TAS:Reactome.
DR   GO; GO:0006631; P:fatty acid metabolic process; IBA:GO_Central.
DR   GO; GO:0006544; P:glycine metabolic process; IDA:UniProtKB.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0019530; P:taurine metabolic process; IDA:UniProtKB.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR016662; Acyl-CoA_thioEstase_long-chain.
DR   InterPro; IPR014940; BAAT_C.
DR   InterPro; IPR006862; Thio_Ohase/aa_AcTrfase.
DR   Pfam; PF08840; BAAT_C; 1.
DR   Pfam; PF04775; Bile_Hydr_Trans; 1.
DR   PIRSF; PIRSF016521; Acyl-CoA_hydro; 1.
DR   SUPFAM; SSF53474; SSF53474; 3.
PE   1: Evidence at protein level;
KW   Acyltransferase; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disease mutation; Fatty acid metabolism;
KW   Hydrolase; Lipid metabolism; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine esterase; Transferase.
FT   CHAIN         1    418       Bile acid-CoA:amino acid N-
FT                                acyltransferase.
FT                                /FTId=PRO_0000202159.
FT   ACT_SITE    235    235       Charge relay system. {ECO:0000305}.
FT   ACT_SITE    328    328       Charge relay system. {ECO:0000305}.
FT   ACT_SITE    362    362       Charge relay system. {ECO:0000305}.
FT   MOD_RES     125    125       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q63276}.
FT   MOD_RES     416    416       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q63276}.
FT   VARIANT      20     20       R -> Q (in dbSNP:rs1572983).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.2, ECO:0000269|Ref.4}.
FT                                /FTId=VAR_052303.
FT   VARIANT      76     76       M -> V (in FHCA; dbSNP:rs28937579).
FT                                {ECO:0000269|PubMed:12704386}.
FT                                /FTId=VAR_023737.
FT   MUTAGEN     235    235       C->A: Abolishes activity.
FT                                {ECO:0000269|PubMed:12239217,
FT                                ECO:0000269|PubMed:12810727}.
FT   MUTAGEN     235    235       C->S: Lowers N-acyltransferase activity;
FT                                enhanced thioesterase activity presumably
FT                                dependent on the formation of a bile
FT                                acid-enzyme covalent intermediate via a
FT                                thioester bond.
FT                                {ECO:0000269|PubMed:12239217,
FT                                ECO:0000269|PubMed:12810727}.
FT   MUTAGEN     328    328       D->A: Abolishes activity.
FT                                {ECO:0000269|PubMed:12239217,
FT                                ECO:0000269|PubMed:12810727}.
FT   MUTAGEN     362    362       H->A: Abolishes activity.
FT                                {ECO:0000269|PubMed:12239217,
FT                                ECO:0000269|PubMed:12810727}.
FT   MUTAGEN     372    372       C->A: Retains activity.
FT   MUTAGEN     417    417       Q->K: Translocation to peroxisomes.
FT                                {ECO:0000269|PubMed:12810727}.
SQ   SEQUENCE   418 AA;  46299 MW;  4B290BAEE97F23B3 CRC64;
     MIQLTATPVS ALVDEPVHIR ATGLIPFQMV SFQASLEDEN GDMFYSQAHY RANEFGEVDL
     NHASSLGGDY MGVHPMGLFW SLKPEKLLTR LLKRDVMNRP FQVQVKLYDL ELIVNNKVAS
     APKASLTLER WYVAPGVTRI KVREGRLRGA LFLPPGEGLF PGVIDLFGGL GGLLEFRASL
     LASRGFASLA LAYHNYEDLP RKPEVTDLEY FEEAANFLLR HPKVFGSGVG VVSVCQGVQI
     GLSMAIYLKQ VTATVLINGT NFPFGIPQVY HGQIHQPLPH SAQLISTNAL GLLELYRTFE
     TTQVGASQYL FPIEEAQGQF LFIVGEGDKT INSKAHAEQA IGQLKRHGKN NWTLLSYPGA
     GHLIEPPYSP LCCASTTHDL RLHWGGEVIP HAAAQEHAWK EIQRFLRKHL IPDVTSQL
//
